[Stable Chronic Obstructive Pulmonary Disease Associated With Cognitive Impairment: Possible Causality Factor]
- PMID: 34181845
- PMCID: PMC8628825
- DOI: 10.31053/1853.0605.v78.n2.28721
[Stable Chronic Obstructive Pulmonary Disease Associated With Cognitive Impairment: Possible Causality Factor]
Abstract
Backgruound: Chronic Obstructive Pulmonary Disease (COPD), a preventable and underdiagnosed pathology, can be defined as a progressive and poorly reversible limitation to airflow as a result of a persistent inflammatory response due to inhalation of harmful substances, particularly tobacco smoke. The disease has a systemic impact. Among other conditions, it may increase the risk of cognitive impairment along with its associated consequences.
Methods: Prospective, cross-sectional, observational and analytical design. The space were COPD patients who visited in two health institutions from June 2017 to September 2018. Non-probabilistic and convenience sampling. Data were collected on demographics, tobacco consumption, comorbidities (Charlson index), a validated scale for dyspnea (MCRm), the main symptom in COPD and the COPD Assessment Test (CAT) were applied along with a history of exacerbation of the disease. The severity of COPD was evaluated by spirometry according to GOLD guideline. Cognitive impairment was assessed using Neuropsi.
Outcomes: The final sample consisted of 44 subjects. According to spirometry and GOLD, 7 patients (15.9%) classified in group 1 (mild), 19 (43.2%) in group 2 (moderate), 11 (25%) in group 3 (severe) and 7 (15.9%) in group 4 (very serious). Of the 44 patients recruited, 28 (63.6%) had normal cognitive function and 16 (36.3%) had some degree of cognitive impairment. Memory was the most compromised function.
Conclusion: Difficulties in recruitment impeded reaching the expected sample size. However, a trend was observed favoring the association. It is important to insist on avoiding smoking because it seems to increase the risk of cognitive impairment that further disrupts the quality of life and makes treatment difficult.
Introducción: La enfermedad pulmonar obstructiva crónica (EPOC) se define como limitación progresiva y poco reversible al flujo aéreo a consecuencia de una respuesta inflamatoria por inhalación sustancias, en particular humo del tabaco. La enfermedad tiene repercusión sistémica y entre otras, puede aumentar el riesgo de deterioro cognitivo.
Materiales y métodos: Diseño prospectivo, transversal, observacional y analítico. El universo fueron pacientes EPOC que consultaron en dos instituciones de salud desde junio de 2017 a septiembre de 2018. Muestreo no probabilístico, por conveniencia. Se recogieron datos demográficos, de comorbilidades, se aplicó la escalaMCRm de disnea y se valoraron antecedentes de exacerbación de la enfermedad. La gravedad de la EPOC se reconoció por espirometría de acuerdo a GOLD. El deterioro cognitivo fue evaluado mediante el Neuropsi.
Resultados: La muestra final incluyó 44 sujetos. De acuerdo a espirometría y GOLD 7 pacientes (15,9 %) clasificaron en el grupo 1 (leve), 19 (43,2 %) en el 2 (moderado), 11 (25 %) en el 3 (grave) y 7 (15,9 %) en el 4 (muy grave). De los 44 pacientes reclutados, 28 (63,6 %) presentaron una función cognitiva normal y 16 (36,3 %), algún grado de alteración cognitiva. La memoria fue la función más comprometida.
Conclusiones: Dificultades en el reclutamiento impidieron alcanzar el tamaño de muestra esperado. Sin embargo, se observó una tendencia a favor de la asociación. Resulta importante insistir en evitar el tabaquismo pues este parece incrementar el riesgo de deterioro cognitivo que perturba aún más la calidad de vida y dificulta el tratamiento.
Keywords: pulmonary disease, chronic obstructive; cognitive dysfunction; tobacco use disorder.
Universidad Nacional de Córdoba
Conflict of interest statement
Figures
Similar articles
-
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):325-356. doi: 10.5507/bp.2020.056. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020. PMID: 33325455
-
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Int J Chron Obstruct Pulmon Dis. 2017 Aug 29;12:2593-2610. doi: 10.2147/COPD.S132236. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28919728 Free PMC article. Review.
-
Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values.Int J Chron Obstruct Pulmon Dis. 2014 Jun 26;9:675-83. doi: 10.2147/COPD.S63485. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 25061286 Free PMC article.
-
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24426780 Free PMC article.
-
Influencing Factors and Exercise Intervention of Cognitive Impairment in Elderly Patients with Chronic Obstructive Pulmonary Disease.Clin Interv Aging. 2020 Apr 21;15:557-566. doi: 10.2147/CIA.S245147. eCollection 2020. Clin Interv Aging. 2020. PMID: 32368022 Free PMC article. Review.
Cited by
-
[Cognitive alterations in patients recovered from COVID-19 treated in Cardiopulmonary Rehabilitation].Rev Med Inst Mex Seguro Soc. 2023 Nov 6;61(6):796-801. doi: 10.5281/zenodo.10064351. Rev Med Inst Mex Seguro Soc. 2023. PMID: 37995338 Free PMC article. Spanish.
-
The influence of physical fatigue on telephone-based neuropsychological test performance in COVID-19 survivors.Eur Arch Psychiatry Clin Neurosci. 2025 Feb;275(1):75-88. doi: 10.1007/s00406-023-01638-2. Epub 2023 Jun 19. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 37336825
References
-
- Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the diagnosis, management, and the prevention of Chronic Obstructive Pulmonary Disease. Report. 2020 Disponible en: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-0... . - PubMed
-
- Echazarreta AL, Arias SJ, Del Olmo R, Giugno ER, Colodenco FD, Arce SC, Bossio JC, Armando G, Soriano JB, Grupo de estudio EPOC.AR Prevalencia de enfermedad pulmonar obstructiva crónica en 6 aglomerados urbanos de Argentina: el estudio EPOC.AR. Arch Bronconeumol. 2018 May;54(5):260–269. doi: 10.1016/j.arbres.2017.09.018. - DOI - PubMed
-
- Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010 Sep 1;182(5):598–604. doi: 10.1164/rccm.200912-1843CC. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous